Article
Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell.
British journal of biomedical science - 1 Jan 2003
Bosson Geoffrey
Abstract excerpt
The cytotoxic drug methotrexate uses the reduced folate carrier for transport into the cell, where it inhibits key enzymes in nucleotide biosynthesis. Resistance to methotrexate can be achieved by altering the genetic code of the reduced folate carrier gene and thus change the structure and function of the protein. Our understanding of RFC structure and function is based on the information gained from studying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
